These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25459555)

  • 1. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
    Berry K; Taylor J; Liou IW; Ioannou GN
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis and survival in patients with cirrhosis.
    Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
    Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis.
    Berry K; Lerrigo R; Liou IW; Ioannou GN
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):118-23. PubMed ID: 26192147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.
    Gaballa D; Bezinover D; Kadry Z; Eyster E; Wang M; Northup PG; Stine JG
    Liver Transpl; 2019 Dec; 25(12):1747-1755. PubMed ID: 31436367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation.
    Hernández Conde M; Llop Herrera E; de la Revilla Negro J; Pons Renedo F; Fernández Puga N; Martínez Porras JL; Trapero Marugan M; Cuervas-Mons V; Sánchez Turrión V; Calleja Panero JL
    Rev Esp Enferm Dig; 2016 Nov; 108(11):716-720. PubMed ID: 27756145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study.
    Karvellas CJ; Cardoso FS; Senzolo M; Wells M; Alghanem MG; Handou F; Kwapisz L; Kneteman NM; Marotta PJ; Al-Judaibi B
    Ann Hepatol; 2017; 16(2):236-436. PubMed ID: 28233745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
    La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
    Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein thrombosis and liver transplant survival benefit.
    Englesbe MJ; Schaubel DE; Cai S; Guidinger MK; Merion RM
    Liver Transpl; 2010 Aug; 16(8):999-1005. PubMed ID: 20677291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis.
    John BV; Konjeti R; Aggarwal A; Lopez R; Atreja A; Miller C; Zein NN; Carey WD
    Ann Hepatol; 2013; 12(6):952-8. PubMed ID: 24114826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
    Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
    Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis.
    Xian J; Tang Y; Shao H; Wang X; Zhang M; Xing T
    Medicine (Baltimore); 2021 Apr; 100(16):e25439. PubMed ID: 33879676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.